YVC-11433-41210
3 vaccinations
1 coded response
39 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 019 / MA
- Registered
- 2021-03-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-08
Registered in v-safe
-
2021-03-08
Dose 1 — Janssen/Johnson & Johnson
- 2021-03-08
-
2021-03-09
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-10
- 2021-03-11
- 2021-03-12
- 2021-03-18
- 2021-03-22
- 2021-03-29
- 2021-04-07
- 2021-04-12
- 2021-04-19
- 2021-06-07
- 2021-09-06
-
2021-10-30
Dose 2 — Pfizer-BioNTech
- 2021-10-30
-
2021-10-31
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-11-01
- 2021-11-02
- 2021-11-03
- 2021-11-04
- 2021-11-05
- 2021-11-06
- 2021-11-15
- 2021-11-20
- 2021-11-28
- 2021-12-04
- 2021-12-11
- 2022-01-29
- 2022-04-30
-
2022-09-09
Dose 3 — Moderna
-
2022-09-10
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-09-11
- 2022-09-12
- 2022-09-16
-
2022-09-23
Survey response — day 14, dose 3MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend schoolFree text: COVID 19MedDRA releases: 2024-11 · check-in free text available
- 2022-10-01
- 2022-10-10
- 2022-10-14
- 2022-10-21
- 2022-12-09
- 2023-03-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-08 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-30 | Pfizer-BioNTech | No |
| 3 | 2022-09-09 | Moderna | No |
Free text
Release 12 — day 14, dose 3
Symptoms: COVID 19
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release